TheraPten BioSciences, Inc. logo

TheraPten BioSciences, Inc.

TheraPten Biosciences is a preclinical biotechnology company focused on to develop anti-cancer protein therapeutics which include PTEN-L(Phosphatase and Tensin Homologue on chromosome Ten-Long) a natural human anti-cancer tumor suppressor protein as an injectable biological therapy.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.therapten.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
101-1865 Dilworth Drive # 705, British Columbia, V1Y 9T1
Kelowna
Canada
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

In 2017,TheraPten received two Industrial Research Assistance Program(IRAP) R&D grants from the Government of Canada.